One-Third of Cancer Patients Have a Genetic Profile Accessible by Their Oncologist

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 24, 2016 – A new market research report titled Personalized Medicine’s Effect on Oncologists’ Treatment Regimens, from Industry Standard Research (ISR), finds that, according to US-based oncologists, currently one-quarter of patients are treated using genetic tumor profiling to inform treatment decisions and … Continued

Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 17, 2016 – A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition), from Industry Standard Research (ISR), indicates that the majority of companies with a large molecule offering plan to enter or are already involved in the … Continued

ISR CUSTOMERS